0001104659-23-083505.txt : 20230724
0001104659-23-083505.hdr.sgml : 20230724
20230724171327
ACCESSION NUMBER: 0001104659-23-083505
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230720
FILED AS OF DATE: 20230724
DATE AS OF CHANGE: 20230724
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hochman David P
CENTRAL INDEX KEY: 0001292834
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39421
FILM NUMBER: 231105820
MAIL ADDRESS:
STREET 1: 15 WESTON HILL RD.
CITY: RIVERSIDE
STATE: CT
ZIP: 06878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Orchestra BioMed Holdings, Inc.
CENTRAL INDEX KEY: 0001814114
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 UNION SQUARE DRIVE
CITY: NEW HOPE
STATE: PA
ZIP: 18938
BUSINESS PHONE: 646-343-9298
MAIL ADDRESS:
STREET 1: 150 UNION SQUARE DRIVE
CITY: NEW HOPE
STATE: PA
ZIP: 18938
FORMER COMPANY:
FORMER CONFORMED NAME: Health Sciences Acquisitions Corp 2
DATE OF NAME CHANGE: 20200603
4
1
tm2321855-10_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-07-20
0
0001814114
Orchestra BioMed Holdings, Inc.
OBIO
0001292834
Hochman David P
C/O ORCHESTRA BIOMED HOLDINGS, INC.
150 UNION SQUARE DRIVE
NEW HOPE
PA
18938
1
1
0
0
See Remarks
0
Common Stock, par value $0.0001 per share ("Common Stock")
2023-07-20
4
A
0
300000
0
A
465498
D
Common Stock
2023-07-20
4
A
0
165000
0
A
227502
I
By the DPH 2008 Trust
Stock Option (Right to Buy)
7.42
2023-07-20
4
A
0
100500
0
A
2033-07-20
Common Stock
100500
100500
D
Stock Option (Right to Buy)
7.42
2023-07-20
4
A
0
132000
0
A
2033-07-20
Common Stock
132000
132000
I
By the DPH 2008 Trust
Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 34% of the shares will vest on the 18-month anniversary of January 26, 2023 (the "Vesting Commencement Date"), (ii) 33% the shares will vest on the two-year anniversary of the Vesting Commencement Date, and (iii) 33% the shares will vest on the three-year anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service through such dates.
The stock options vest over a four-year period as follows: (i) 25% of the underlying shares will vest on the one-year anniversary of the Vesting Commencement Date and (ii) 75% of the underlying shares will vest in equal installments on a quarterly basis on the last day of each quarter, starting on the last day of the first quarter after the first anniversary of the Vesting Commencement Date, or March 31, 2024, subject to the Reporting Person's continuous service through such dates.
Chief Executive Officer and Chairperson
/s/ Matthew R. Schob, Attorney-in-Fact
2023-07-24